Compare Nuvalent Inc (NUVL) vs Vanguard Ultra Short Bond ETF (VUSB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs Vanguard Ultra Short Bond ETF — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Vanguard Ultra Short Bond ETF trades at $49.71. The key difference: Nuvalent Inc is trading nearer its 52-week high, Vanguard Ultra Short Bond ETF nearer its low. Which is the better fit depends on your goals.
| NUVL | VUSB | |
|---|---|---|
Market Cap | $9.81B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $123.96 | $50.03 |
52-Week Low | $72.16 | $49.60 |
Enterprise Value | $8.52B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About Vanguard Ultra Short Bond ETF
VUSB is an actively managed ETF from Vanguard that invests in a diversified portfolio of high-quality, investment-grade fixed income securities with maturities typically under two years. It is designed to offer higher yield potential than traditional money market funds while maintaining limited price volatility, making it a strategic tool for managing short-term reserves with a 6-to-18-month horizon.
Read more on VUSB →
